Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (261-270 of 366) with videos related to

Pageof 37
Sort By:
Haematology and Blood Transfusion|January 1, 1987
Leukemic colony-forming cells in acute myeloblastic leukemia: maturation hierarchy and growth conditionsF Herrmann, W Oster, A Lindemann, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
The American Journal of Medicine|October 1, 1977
Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphologyB Koziner, D A Filippa, R Mertelsmann, et al.
International Journal of Cancer|October 21, 1991
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitroT Licht, H H Fiebig, K J Bross, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Cytokine gene transfer in cancer therapyL Cao, P Kulmburg, H Veelken, et al.
Journal of Biological Response Modifiers|October 1, 1984
Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.
Cancer Research|January 1, 1985
Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytesV J Merluzzi, D M Savage, L Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemiaP Benedetto, R Mertelsmann, T H Szatrowski, et al.
Biotechnology Therapeutics|January 1, 1991
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndromeF Herrmann, R Mertelsmann, A Lindemann, et al.
Pageof 37

Showing results (261-270 of 366) with videos related to

Sort By:
Pageof 37
Haematology and Blood Transfusion|January 1, 1987
Leukemic colony-forming cells in acute myeloblastic leukemia: maturation hierarchy and growth conditionsF Herrmann, W Oster, A Lindemann, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
Oncology|July 1, 1997
Dacarbazine and interferon alpha for stage IV malignant melanomaI Tamm, H Grimme, E Bergen, et al.
The American Journal of Medicine|October 1, 1977
Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphologyB Koziner, D A Filippa, R Mertelsmann, et al.
International Journal of Cancer|October 21, 1991
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitroT Licht, H H Fiebig, K J Bross, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Cytokine gene transfer in cancer therapyL Cao, P Kulmburg, H Veelken, et al.
Journal of Biological Response Modifiers|October 1, 1984
Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.
Cancer Research|January 1, 1985
Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytesV J Merluzzi, D M Savage, L Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemiaP Benedetto, R Mertelsmann, T H Szatrowski, et al.
Biotechnology Therapeutics|January 1, 1991
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndromeF Herrmann, R Mertelsmann, A Lindemann, et al.
Pageof 37